Oppenheimer Upgrades Arch Chemicals (ARJ) to Outperform
More News related to ARJ
- Arch Chemicals (ARJ) Tops Q3 EPS by 11c; Issues Mixed Guidance for Q4 and FY09
- Arch Chemicals Reports Third Quarter 2009 Earnings and Narrows Its Full-Year 2009 Earnings Guidance
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- Arch Chemicals (ARJ) Declares $0.20 Dividend; 2.8% Yield
- Arch Chemicals, Inc. Declares Quarterly Dividend
More News related to Upgrades
- Copart (CPRT) Reports Q1 EPS of $0.42, Beats by 1c
- PDL BioPharma (PDLI) Reports Q4 Revenues
- Shanda Games (GAME) Reports Q3 Adj-EPS of $0.24
- American Technology (ATCO) Posts Q3 Loss of 3c, Misses Views; Revs Higher Y/Y
- American Technology (ATCO) Reports '09 Financials
Oppenheimer upgrades Arch Chemicals (NYSE: ARJ) from Market Perform to Outperform. Price target $32.
Arch Chemicals, Inc. (Arch) is a global biocides company. The Company provides chemistry-based and related solutions to selectively destroy and control the growth of harmful microbes.
Related Categories
UpgradesStocks Mentioned
+0.13Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
